MedTrace Logo

Breast-Sparing Proton Therapy for Hodgkin's Disease

NCT02070393 · Status: TERMINATED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2015-02-04

No results posted yet for this study

Summary

The purpose of this study is to drastically reduce unnecessary breast dose in young females with Hodgkin's Disease who require radiation therapy.

Conditions

  • Hodgkins Disease

Interventions

RADIATION

Proton

14-24 Radiation treatments using Protons

Sponsors & Collaborators

  • Indiana University

    lead OTHER

Principal Investigators

  • Jeffery Buchsbuam, MD · Indiana University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Years
Max Age
30 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-02-28
Completion
2015-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02070393 on ClinicalTrials.gov